Regulation of Intracellular Human Immunodeficiency Virus Type-1 Protease Activity

By Gatlin J.   Arrigo S.J.   Schmidt M.G.  

Virology, Vol. 244, Iss. 1, 1998-04 ,pp. : 87-96

Elsevier

Access to resources Recommend Favorite

Identification of cis-Acting Repressor Activity within Human Immunodeficiency Virus Type 1 Protease Sequences

By Huffman K.M.   Arrigo S.J.  

Virology, Vol. 234, Iss. 2, 1997-08 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite

Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines

By Kjerrstrom A.   Hinkula J.   Engstrom G.   Ovod V.   Krohn K.   Benthin R.   Wahren B.  

Virology, Vol. 284, Iss. 1, 2001-05 ,pp. : 46-61

Elsevier

Access to resources Recommend Favorite

Virological Importance of the Protease-Cleavage Site in Human Immunodeficiency Virus Type 1 Nef Is Independent of both Intravirion Processing and CD4 Down-regulation

By Pandori M.   Craig H.   Moutouh L.   Corbeil J.   Guatelli J.  

Virology, Vol. 251, Iss. 2, 1998-11 ,pp. : 302-316

Elsevier

Access to resources Recommend Favorite

Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus

By Molla A.   Vasavanonda S.   Kumar G.   Sham H.L.   Johnson M.   Grabowski B.   Denissen J.F.   Kohlbrenner W.   Plattner J.J.   Leonard J.M.   Norbeck D.W.   Kempf D.J.  

Virology, Vol. 250, Iss. 2, 1998-10 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite